low dose human recombinant interleukin-2 (Central South University)

N/A

Report date: 2025/03/20 15:46:46

Base Information

Drug Namelow dose human recombinant interleukin-2 (Central South University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsUrticaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCentral South University
China Registration ClassN/A

Develop Information

Active CompaniesCentral South University
Inactive CompaniesN/A
Active IndicationsUrticaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A